<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content='Data on recurrences of bladder cancer, used by many people
  to demonstrate methodology for recurrent event modelling.
Bladder1 is the full data set from the study. It contains all three treatment
arms and all recurrences for 118 subjects; the maximum observed number
of recurrences is 9.
Bladder is the data set that appears most commonly in the literature. 
It uses only the 85 subjects with nonzero follow-up who were
assigned to either thiotepa or placebo, and only the first four recurrences
for any patient.  The status variable is 1 for
recurrence and 0 for everything else (including death for any reason).
The data set is laid out in the competing risks format of the paper by
Wei, Lin, and Weissfeld.
Bladder2 uses the same subset of subjects as bladder, but formatted in the
(start, stop] or Anderson-Gill style.  
Note that in transforming from the WLW to the AG style data set there
is a quite common programming mistake that leads to extra follow-up time
for 12 subjects: all those with follow-up beyond their 4th recurrence.
This "follow-up" is a side effect of throwing away all events after the
fourth while retaining the last follow-up time variable from the
original data.  The bladder2 data set found here does not make this
mistake, but some analyses in the literature have done so; it results
in the addition of a small amount of immortal time bias and 
shrinks the fitted coefficients towards zero.'><title>Bladder Cancer Recurrences — bladder • survival</title><!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png"><link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png"><link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png"><link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Bladder Cancer Recurrences — bladder"><meta property="og:description" content='Data on recurrences of bladder cancer, used by many people
  to demonstrate methodology for recurrent event modelling.
Bladder1 is the full data set from the study. It contains all three treatment
arms and all recurrences for 118 subjects; the maximum observed number
of recurrences is 9.
Bladder is the data set that appears most commonly in the literature. 
It uses only the 85 subjects with nonzero follow-up who were
assigned to either thiotepa or placebo, and only the first four recurrences
for any patient.  The status variable is 1 for
recurrence and 0 for everything else (including death for any reason).
The data set is laid out in the competing risks format of the paper by
Wei, Lin, and Weissfeld.
Bladder2 uses the same subset of subjects as bladder, but formatted in the
(start, stop] or Anderson-Gill style.  
Note that in transforming from the WLW to the AG style data set there
is a quite common programming mistake that leads to extra follow-up time
for 12 subjects: all those with follow-up beyond their 4th recurrence.
This "follow-up" is a side effect of throwing away all events after the
fourth while retaining the last follow-up time variable from the
original data.  The bladder2 data set found here does not make this
mistake, but some analyses in the literature have done so; it results
in the addition of a small amount of immortal time bias and 
shrinks the fitted coefficients towards zero.'><meta property="og:image" content="/logo.png"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">survival</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">3.5-6</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/example-analysis.html">Example Analysis</a>
  </div>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/therneau/survival/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Bladder Cancer Recurrences</h1>
      
      <div class="d-none name"><code>bladder.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Data on recurrences of bladder cancer, used by many people
  to demonstrate methodology for recurrent event modelling.</p>
<p>Bladder1 is the full data set from the study. It contains all three treatment
arms and all recurrences for 118 subjects; the maximum observed number
of recurrences is 9.</p>
<p>Bladder is the data set that appears most commonly in the literature. 
It uses only the 85 subjects with nonzero follow-up who were
assigned to either thiotepa or placebo, and only the first four recurrences
for any patient.  The status variable is 1 for
recurrence and 0 for everything else (including death for any reason).
The data set is laid out in the competing risks format of the paper by
Wei, Lin, and Weissfeld.</p>
<p>Bladder2 uses the same subset of subjects as bladder, but formatted in the
(start, stop] or Anderson-Gill style.  
Note that in transforming from the WLW to the AG style data set there
is a quite common programming mistake that leads to extra follow-up time
for 12 subjects: all those with follow-up beyond their 4th recurrence.
This "follow-up" is a side effect of throwing away all events after the
fourth while retaining the last follow-up time variable from the
original data.  The bladder2 data set found here does not make this
mistake, but some analyses in the literature have done so; it results
in the addition of a small amount of immortal time bias and 
shrinks the fitted coefficients towards zero.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="va">bladder1</span></span>
<span><span class="va">bladder</span></span>
<span><span class="va">bladder2</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">cancer</span>, package<span class="op">=</span><span class="st">"survival"</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="format">Format<a class="anchor" aria-label="anchor" href="#format"></a></h2>
    <p>bladder1</p><table class="table table"><tr><td>id:</td><td>Patient id</td></tr><tr><td>treatment:</td><td>Placebo, pyridoxine (vitamin B6), or thiotepa</td></tr><tr><td>number:</td><td>Initial number of tumours (8=8 or more)</td></tr><tr><td>size:</td><td>Size (cm) of largest initial tumour</td></tr><tr><td>recur:</td><td>Number of recurrences</td></tr><tr><td>start,stop:</td><td>The start and end time of each time interval</td></tr><tr><td>status:</td><td>End of interval code, 0=censored, 1=recurrence,</td></tr><tr><td></td><td>2=death from bladder disease, 3=death other/unknown cause</td></tr><tr><td>rtumor:</td><td>Number of tumors found at the time of a recurrence</td></tr><tr><td>rsize:</td><td>Size of largest tumor at a recurrence</td></tr><tr><td>enum:</td><td>Event number (observation number within patient)</td></tr></table><p>bladder</p><table class="table table"><tr><td>id:</td><td>Patient id</td></tr><tr><td>rx:</td><td>Treatment 1=placebo  2=thiotepa</td></tr><tr><td>number:</td><td>Initial number of tumours (8=8 or more)</td></tr><tr><td>size:</td><td>size (cm) of largest initial tumour</td></tr><tr><td>stop:</td><td>recurrence or censoring time</td></tr><tr><td>enum:</td><td>which recurrence (up to 4)</td></tr></table><p>bladder2</p><table class="table table"><tr><td>id:</td><td>Patient id</td></tr><tr><td>rx:</td><td>Treatment 1=placebo  2=thiotepa</td></tr><tr><td>number:</td><td>Initial number of tumours (8=8 or more)</td></tr><tr><td>size:</td><td>size (cm) of largest initial tumour</td></tr><tr><td>start:</td><td>start of interval (0 or previous recurrence time)</td></tr><tr><td>stop:</td><td>recurrence or censoring time</td></tr><tr><td>enum:</td><td>which recurrence (up to 4)</td></tr></table></div>
    <div class="section level2">
    <h2 id="source">Source<a class="anchor" aria-label="anchor" href="#source"></a></h2>
    <p>Andrews DF, Hertzberg AM (1985), 
DATA: A Collection of Problems from Many Fields for the Student 
and Research Worker, New York: Springer-Verlag.</p>
<p>LJ Wei, DY Lin, L Weissfeld (1989),
  Regression analysis of multivariate incomplete failure time data by
  modeling marginal distributions.
  <em>Journal of the American Statistical Association</em>,
  <b>84</b>.</p>
    </div>

  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Terry M Therneau.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer></div>

  

  

  </body></html>

